Literature DB >> 15705299

Azoospermia factor (AZF) in Yq11: towards a molecular understanding of its function for human male fertility and spermatogenesis.

Peter H Vogt1.   

Abstract

The Y chromosomal azoospermia factor (AZF) is essential for human spermatogenesis. It has been mapped by molecular deletion analyses to three subintervals in Yq11, AZFa, AZFb, and AZFc, containing a number of genes of which at least some control, post-transcriptionally, the RNA metabolism of other spermatogenesis genes, functionally expressed at different phases of the spermatogenic cycle. Intrachromosomal recombination events between homologous large repetitive sequence block in Yq11 are now recognized as the major cause of the AZFa, AZFb and AZFc microdeletions, and an overlap of the AZFb and AZFc regions was revealed by sequence analysis of the complete Yq11 region. The increasing knowledge of the expression patterns of AZF genes in human germ cells suggests that the DBY gene is the major AZFa gene, the RBMY gene the major AZFb gene, although a functional expression of the other AZFa/b genes in the male germ line is also most likely. Genetic redundancy might exist in AZFc because a number of gene copies in the large P1 palindrome structure in distal AZFc were found to be deleted also in fertile men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705299     DOI: 10.1016/s1472-6483(10)60807-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  28 in total

1.  Expression analysis of RNA-binding motif gene on Y chromosome (RBMY) protein isoforms in testis tissue and a testicular germ cell cancer-derived cell line (NT2).

Authors:  Mehdi Alikhani; Mehdi Sharifi Tabar; Shahab Mirshahvaladi; Abolfazl Kheimeh; Mohammad Ali Sadighi Gilani; Marjan Sabbaghian
Journal:  Iran Biomed J       Date:  2013-04

Review 2.  A multi-faceted approach to understanding male infertility: gene mutations, molecular defects and assisted reproductive techniques (ART).

Authors:  Eisa Tahmasbpour; Dheepa Balasubramanian; Ashok Agarwal
Journal:  J Assist Reprod Genet       Date:  2014-08-13       Impact factor: 3.412

3.  Prevalent false positives of azoospermia factor a (AZFa) microdeletions caused by single-nucleotide polymorphism rs72609647 in the sY84 screening of male infertility.

Authors:  Qing Wu; Guo-Wu Chen; Tao-Fei Yan; Hui Wang; Yu-Ling Liu; Zheng Li; Shi-Wei Duan; Fei Sun; Yun Feng; Hui-Juan Shi
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

Review 4.  Y chromosome azoospermia factor region microdeletions and transmission characteristics in azoospermic and severe oligozoospermic patients.

Authors:  Xiao-Wei Yu; Zhen-Tong Wei; Yu-Ting Jiang; Song-Ling Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Cytogenetic abnormalities and azoospermia factor (AZF) microdeletions in infertile men from Kuwait.

Authors:  Moussa Alkhalaf; Kamal Al-Shoumer
Journal:  J Mol Genet Med       Date:  2010-04-26

6.  Identification of Y chromosome microdeletions in infertile Turkish men.

Authors:  Ali Şahin Küçükaslan; Vildan Bozok Çetintaş; Raşit Altıntaş; Aslı Tetik Vardarlı; Zeynep Mutlu; Murat Ulukuş; Bülent Semerci; Zuhal Eroğlu
Journal:  Turk J Urol       Date:  2013-09

7.  Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men.

Authors:  O Akinloye; J Gromoll; E Nieschlag; M Simoni
Journal:  J Endocrinol Invest       Date:  2009-11       Impact factor: 4.256

8.  Sperm chromatin proteomics identifies evolutionarily conserved fertility factors.

Authors:  Diana S Chu; Hongbin Liu; Paola Nix; Tammy F Wu; Edward J Ralston; John R Yates; Barbara J Meyer
Journal:  Nature       Date:  2006-08-30       Impact factor: 49.962

9.  A novel testis-enriched gene Spata33 is expressed during spermatogenesis.

Authors:  Hengling Chen; Minhan Yi; Yue Sheng; Hanhua Cheng; Rongjia Zhou
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

Review 10.  A comprehensive review of genetics and genetic testing in azoospermia.

Authors:  Alaa J Hamada; Sandro C Esteves; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.